older – Talk Bio

France pauses chikungunya vaccinations in the elderly after patient death

1 month ago talkbio0Tagged Adverse event, Age, Chikungunya Fever, Disease Outbreaks, Elderly (population group), France, Latex Fixation Tests, older, Reunion Island, Vaccination, Vaccines

Vaccines, Chikungunya Fever, Elderly (population group), Adverse event, France, Latex Fixation Tests, Reunion Island, Disease Outbreaks, Age, older, Vaccination

Novartis Prepares to File Intrathecal Zolgensma for Older SMA Patients by Mid-2025

3 months ago talkbio0Tagged gene therapy, intrathecal delivery, older, Spinal Muscular Atrophy, Zolgensma

Zolgensma, intrathecal delivery, spinal muscular atrophy, gene therapy, older patients

Novartis Achieves Pivotal Trial Success for Intrathecal Zolgensma in Older SMA Patients After FDA Delay

5 months ago talkbio0Tagged Approved, intrathecal formulation, Novartis, older, Phase 3 trial, Spinal Muscular Atrophy, United States Food and Drug Administration, Zolgensma

Novartis, Zolgensma, Intrathecal formulation, Spinal muscular atrophy (SMA), FDA approval, Pivotal phase 3 trial, Older SMA patients

CDC Recommends Pneumococcal Vaccination for Adults 50 Years and Older

8 months ago talkbio0Tagged Administration of vaccine product containing only Streptococcus pneumoniae antigen (procedure), Adult, Centers for Disease Control and Prevention (U.S.), older, pneumococcal disease prevention, Recommendation, respiratory season

Pneumococcal vaccination, CDC recommendations, adults 50 and older, pneumococcal disease prevention, winter respiratory season.

CDC Expands RSV Vaccine Recommendations for Adults 75 and Older

12 months ago talkbio0Tagged Adult, Centers for Disease Control and Prevention (U.S.), older, public health medicine (field), Recommendation, Respiratory Syncytial Virus Vaccines, Vaccination

RSV vaccine, CDC, adults 75 and older, vaccination recommendations, public health